Multiple sclerosis and glutamate excitotoxicity

Milos Kostic1, Nikola Zivkovic, Ivana Stojanovic

  • 1Departement of Immunology, Faculty of Medicine, University of Nis, 18000 Nis, Serbia. milosh.kostic@hotmail.com

Insights

Glutamate excitotoxicity, involving excessive glutamate signaling, is a key factor in multiple sclerosis (MS) neurodegeneration beyond inflammation. Understanding this mechanism is crucial for MS treatment strategies.

Area of Science:

  • Neuroscience
  • Neuroimmunology
  • Neurodegeneration

Background:

  • Multiple sclerosis (MS) was historically viewed primarily through the lens of neuroinflammation.
  • Emerging evidence highlights inflammation-independent neurodegenerative processes in MS, including mitochondrial dysfunction, iron deposition, and oxidative stress.

Purpose of the Study:

  • To explore glutamate excitotoxicity as a potential link between inflammatory and neurodegenerative pathways in multiple sclerosis.
  • To revise current understanding of elevated extracellular glutamate, receptor alterations, and transporter/enzyme changes in MS.

Main Methods:

  • Review and synthesis of existing data on glutamate excitotoxicity in the context of multiple sclerosis.
  • Analysis of the role of glutamate homeostasis disruption in central nervous system (CNS) damage in MS.

Main Results:

  • Glutamate excitotoxicity, caused by excessive glutamate receptor activation, induces cell death and may bridge inflammatory and neurodegenerative aspects of MS.
  • Disturbances in glutamate homeostasis impact CNS cell communication and function, contributing to diverse pathological events in MS.

Conclusions:

  • Glutamate excitotoxicity is a significant mechanism of CNS damage in multiple sclerosis.
  • Further research is needed on glutamate sources, receptor/transporter alterations, and the molecular mechanisms of excitotoxic damage in MS.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...